(a) Identification. A breast lesion documentation system is a device for use in producing a surface map of the breast as an aid to document palpable breast lesions identified during a clinical breast examination.
(b) Classification. Class II (special controls). The special control is FDA's guidance entitled ``Class II Special Controls Guidance Document: Breast Lesion Documentation System.'' See Sec. 884.1(e) for the availability of this guidance document. [68 FR 44415, Aug. 27, 2003]